KCNV2
protein-codingpotassium voltage-gated channel modifier subfamily V member 2, the group of Potassium voltage-gated channels
Gene summary
Voltage-gated potassium (Kv) channels represent the most complex class of voltage-gated ion channels from both functional and structural standpoints. Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume. This gene encodes a member of the potassium voltage-gated channel subfamily V. This member is identified as a 'silent subunit', and it does not form homomultimers, but forms heteromultimers with several other subfamily members. Through obligatory heteromerization, it exerts a function-altering effect on other potassium channel subunits. This protein is strongly expressed in pancreas and has a weaker expression in several other tissues. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~12.5 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0012475
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0012475
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0012475
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0012475
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0019118
Submitter: ClinGen
The *KCNV2* gene was first reported in relation to "cone dystrophy with supernormal rod responses" (CDSRR) with an autosomal recessive mode of inheritance in 2005 (PMID: 15722315, PMID:16909397). This disease is also referred to as retinal cone dystrophy 3B (MIM#: 610356). Probands have also been reported with similar diagnoses such as cone dystrophy or "achromatopsia and congenital cone dysfunction" (PMID: 18235024), so all of these cases have been lumped for the purposes of this gene curation under the more general disease term KCNV2-related retinopathy. This curation has scored genetic evidence from the first paper linking the phenotype with variants in the *KCNV2* gene by linkage analysis and Sanger sequencing in one family, followed by the analysis of a cohort of 10 additional probands (PMID:16909397). These probands have been included in the present curation, along with others from a cohort of 17 patients from 13 families ((PMID: 18235024). Numerous publications have collectively reported over 180 disease-causing variants, all of which are inferred to lead to loss-of-function. The variant types range from missense, in-frame indels, nonsense, and frameshift variants to large deletions and complex rearrangements. More cases were availbable in the literature, but the maximum score for genetic evidence had already been reached. The *KCNV2* encodes the regulatory subunit (Kv8.2) of voltage-gated potassium channels. These channels control the excitability of electrically active cells, and are made up of 4 subunits that create the central ion channel (PMID: 34063002). Disease-associated missense variants in yeast two-hybrid studies exhibit defective protein interaction with the *KCNB1* gene product Kv2.1 (PMID: 21882291), consistent with a loss-of-function mechanism of pathogenicity. Disease-associated missense variants also exhibit loss of interaction and altered electrophysiological function when exogenously expressed in HEK293 cells (PMID: 23115240). *Kcnv2* knockout mice exhibit a depressed a-wave and elevated b-wave, recapitulating the human abnormal response, accompanied by retinal changes including increased TUNEL-positive cells (PMID: 30820446). In summary, *KCNV2* is definitively associated with KCNV2-related retinopathy. This has been repeatedly demonstrated in both research and diagnostic settings, and has been upheld over time without the emergence of contradictory evidence, leading to a definitive classification. This classification has been approved by the ClinGen Retina GCEP on September 7th, 2023 (SOP Version 10).
Clinical Genomic Database (CGD)
Manifestation: Ophthalmologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to KCNV2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_133497.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 7 | 215 | 2 | 224 | ||
| missense | 4 | 28 | 465 | 43 | 3 | 543 |
| nonsense | 25 | 21 | 2 | 48 | ||
| start loss | 1 | 1 | ||||
| frameshift | 17 | 14 | 3 | 34 | ||
| splice donor/acceptor (+/-2bp) | 1 | 1 | ||||
| Total | 46 | 65 | 477 | 258 | 5 | 851 |
Highest pathogenic variant AF is 0.00025096885
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_598004.1 | 2 | MANE Select | |
| Ensembl | ENSP00000371514.3 | 2 | MANE Select |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Neuronal System
- Voltage gated Potassium channels
- Potassium Channels
Biological Process
- regulation of ion transmembrane transport
- protein homooligomerization
- potassium ion transmembrane transport
Molecular Function
- voltage-gated potassium channel activity
Cellular Component
- plasma membrane
- voltage-gated potassium channel complex
- integral component of membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000382082
- Coding exons
- 2
- Length
- 12536
- Individuals with no LoFs
- 125633
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 115
- Defined
- 125748
- p
- 0.000457
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -4.48 | 606 | 365 | 1.66 | 0.0000280 | 3503 |
| Missense (PolyPhen) | 216 | 133.17 | 1.622 | 1282 | ||
| Synonymous | -5.24 | 253 | 167 | 1.52 | 0.0000145 | 1099 |
| Loss of Function | -3.30 | 31 | 16.5 | 1.88 | 7.28e-7 | 175 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00056 | 0.00055 | rare |
| Latino/Admixed American | 0.00079 | 0.00078 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00050 | 0.00049 | rare |
| Finnish | 0.00020 | 0.00018 | rare |
| European (Non-Finnish) | 0.00046 | 0.00044 | rare |
| South Asian | 0.00040 | 0.00039 | rare |
| Other | 0.00068 | 0.00065 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Potassium channel subunit. Modulates channel activity by shifting the threshold and the half-maximal activation to more negative values.;
- Disease
- DISEASE: Cone dystrophy retinal 3B (RCD3B) [MIM:610356]: A rare form of cone dystrophy associated with supernormal rod responses. The disorder is characterized by reduced visual acuity, photoaversion, night blindness, and abnormal color vision. At an early age, the retina shows subtle depigmentation at the macula and, later, more obvious areas of atrophy. {ECO:0000269|PubMed:16909397}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.122
Intolerance Scores
- LoFtool
- 0.0969
- RVIS EVS
- -0.84
- RVIS percentile EVS
- 11.45
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.630
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |